A growing body of research shows that exposure to air pollution, especially during pregnancy and childhood, may have a negative impact on brain development. Now a study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, has found that exposure to nitrogen dioxide (NO2) during the first […]
Rheumatoid arthritis causally linked to increased risk of age-related macular degeneration, suggests a study published in the Medicine (Baltimore). This study’s goal is to evaluate if there is a causal connection between rheumatoid arthritis (RA) and age-related macular degeneration (AMD), despite past epidemiological studies suggesting an association between the 2 disorders. The impact of RA […]
USA: Tirzepatide (Zepbound), in both the 10 mg or 15 mg dose, reduces sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity, according to topline results from the phase 3 SURMOUNT-OSA clinical trial announced by Eli Lilly and Company. Tirzepatide significantly reduced the apnea-hypopnea index (AHI) relative […]
Mycobacterium avium complex pulmonary disease (MAC-PD) with cavitary lesions presents a significant challenge in clinical management, with uncertain outcomes. Understanding the impact of treatment response on mortality is crucial for optimizing patient care. A recent study aimed to investigate whether achieving sputum culture conversion is associated with improved prognosis in patients with cavitary MAC-PD. This […]
Heart failure patients may one day be able to restore cardiac function with medications that revive the body’s ability to regenerate heart muscle, a novel study at UT Southwestern Medical Center suggests. Heart failure affects close to 30 million people worldwide. An underlying cause is the inability of the adult myocardium-the muscle layer that helps […]
Govorestat was found to be clinically beneficial for patients with sorbitol dehydrogenase (SORD) deficiency, according to interim results from the phase 3 INSPIRE trial. The INSPIRE trial is a Phase 3 double-blind placebo-controlled registrational study evaluating the effect of once-daily (QD) oral govorestat (AT-007) in 56 patients aged 16-55 with SORD Deficiency in the US […]
New Delhi: Aiming to transform the Central Government Health Scheme (CGHS) ecosystem and improve the healthcare experience for all beneficiaries, the Union Ministry of Health and Family Welfare announced a collaboration with the Quality Council of India. A press release issued in this regard stated that this partnership aims to deliver a more robust, efficient, and […]
Mumbai: The medical students enrolled at Wardha-based Mahatma Gandhi Institute of Medical Sciences (MGIMS) are upset over the sudden mid-course hike in the college fees and hostel charges. While for the academic year 2022-2023, the students had to pay Rs 35,000 as additional charges, they are now required to pay Rs 75,800 for the academic year […]
New Delhi: Reviewing the active post-marketing surveillance (PMS) protocol of fixed-dose combination (FDC) Dutasteride plus Silodosin presented by Akums Drugs and Pharmaceuticals, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the firm to modify inclusion criteria by reducing the Prostate-Specific Antigen (PSA) level to less than 4 […]
Mumbai: Piramal Pharma Limited has informed through a recent BSE filing that the US Food and Drug ADministration (US FDA) has issued an Establishment Inspection Report (EIR) for the Riverview, USA manufacturing facility and the inspection has now been successfully closed by the US FDA. Medical Dialogues team had earlier reported that the US FDA had concluded a Pre-Approval […]